Bevacizumab/ifosfamide/sorafenibNeurotoxicity: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2012年 / 1409卷 / 1期

关键词：

Sarcoma; Renal Cell Carcinoma; Bevacizumab; Methylene Blue; Sorafenib;

D O I：

10.2165/00128415-201214090-00045

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：15 / 15

相关论文

共 50 条

[1] Dexamethasone/ifosfamide/methotrexateDelirium: 3 case reports
Reactions Weekly, 2015, 1578 (1) : 119 - 119
[2] Bevacizumab/ranibizumabEndophthalmitis: 3 case reports
Reactions Weekly, 2015, 1576 (1) : 61 - 61
[3] Bevacizumab/corticosteroidsOsteonecrosis: 3 case reports
Reactions Weekly, 2013, 1444 (1) : 11 - 11
[4] Ifosfamide/ondansetron/tramadolNeurotoxicity and encephalopathy: 3 case reports
Reactions Weekly, 2018, 1708 (1) : 171 - 171
[5] Doxorubicin/ifosfamide/trabectedinVarious toxicities: 3 case reports
Reactions Weekly, 2018, 1733 (1) : 151 - 151
[6] Cisplatin/ifosfamide/paclitaxelVarious toxicities: 3 case reports
Reactions Weekly, 2012, 1406 (1) : 15 - 15
[7] Bevacizumab/cetuximabPulmonary toxicities: 3 case reports
Reactions Weekly, 2021, 1868 (1) : 113 - 113
[8] Bevacizumab/doxorubicinMyelosuppression and hypertension: 3 case reports
Reactions Weekly, 2022, 1888 (1) : 103 - 103
[9] Bevacizumab/fluorouracilOral mucositis: 3 case reports
Reactions Weekly, 2011, 1370 (1) : 11 - 11
[10] Bevacizumab/dexamethasoneVarious toxicities: 3 case reports
Reactions Weekly, 2018, 1713 (1) : 64 - 64

← 1 2 3 4 5 →